All sponsors

Haisco Pharmaceutical Group Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS30
PHASE 3 / 2-311
RECRUITING12
READOUTS ≤12 MONTHS14
READOUT SLIPPED >6 MO0%

Delay Index: of 8 active trials registered more than a year ago, 0 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Haisco Pharmaceutical Group Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
HSK39004 Dry Powder Inhaler -0.75mg BID
NCT07140328
P2RecruitingChronic Obstructive Lung Disease (COLD)502025-07-10
HSK39004 inhalation suspension
NCT07331402
P2Active, not recruitingCOPD Patients122025-12-30
HSK31858
NCT06820749
P2Enrolling by invitationAsthma Bronchiale; Bronchiectasis3092026-04-23
HSK44459
NCT06902428
P2Not yet recruitingBehcet's Disease1202026-06-05
HSK39004 Dry Powder Inhaler-0.75mg
NCT07108699
P2Active, not recruitingChronic Obstructive Pulmonary Disease (COPD)1802026-08-30
IPF
NCT07019090
P2Not yet recruitingIdiopathic Pulmonary Fibrosis (IPF)1202026-10-31
HSK55718 dose level 1
NCT07551739
P2Not yet recruitingPain After Surgery2002026-11
HSK44459 dose level 1
NCT07150988
P2Not yet recruitingPsoriasis1502026-11-06
HSK55718 dose level1
NCT07533786
P2RecruitingPain After Surgery2002026-11-22
HSK31858, tablet
NCT06660992
P3RecruitingNon-cystic Fibrosis Bronchiectasis6692026-11-28
HSK39297 200mgQD
NCT07616700
P2RecruitingIgA Nephropathy (IgAN)732026-12-05
HSK47388
NCT07158268
P2Not yet recruitingPlaque Psoriasis2202026-12-20
HSK44459 Cream
NCT07623486
P1/2Active, not recruitingPsoriasis1802027-03
HSK39297 tablets
NCT06745622
P2RecruitingParoxysmal Nocturnal Hemoglobinuria472027-06
HSK39004 Inhalation Suspension
NCT07658339
P3Not yet recruitingCOPD (Chronic Obstructive Pulmonary Disease)3872027-06-11
HSK39004 Dry Powder Inhaler -0.75mg BID
NCT07425210
P2Not yet recruitingChronic Obstructive Lung Disease (COLD)3002027-07
HSK44459 tablets
NCT07070739
P2Not yet recruitingBechet's Disease1202027-07
HSK16149 20mg-40mg BID
NCT06422117
P3Not yet recruitingCentral Neuropathic Pain4082027-07-30
HSK39004 Dry Powder Inhaler Simulant
NCT07583849
P3RecruitingCOPD (Chronic Obstructive Pulmonary Disease)3762027-09-30
HSK47388
NCT07335055
P2RecruitingUlcerative Colitis (UC)1502027-10-15
HSK39297 200mgQD
NCT07363460
P2RecruitingLupus Nephritis (LN)1052027-11-05
HSK39297
NCT07390123
P3RecruitingIgA Nephropathy (IgAN)3702027-12
HSK39004 Inhalation Suspension
NCT07634367
P3Not yet recruitingCOPD (Chronic Obstructive Pulmonary Disease)3002027-12-24
HSK44459
NCT07519070
P3Not yet recruitingIPF4202028-04-05
IPF
NCT07728721
P2Not yet recruitingIdiopathic Pulmonary Fibrosis (IPF)1752028-04-10
HSK3486
NCT07510945
P3Not yet recruitingGeneral Anesthetic4002028-05
PPF
NCT07503587
P3Not yet recruitingProgressive Pulmonary Fibrosis3782028-12-30
HSK31858, tablet
NCT07616375
P3RecruitingNon-cystic Fibrosis Bronchiectasis6692029-01-10
HSK31679
NCT07581951
P3RecruitingMASH - Metabolic Dysfunction-Associated Steatohepatitis; NASH (Non-Alcoholic Steatohepatitis)8862029-06-30
HSK42360-Na Tablets
NCT07790510
P1/2RecruitingMetastatic Colorectal Cancer (CRC)1802029-09-30